Search Results for: press release

Karolinska vice-chancellor resigns following criticism of Macchiarini investigation

Anders Hamsten announced he would be resigning as vice-chancellor from Karolinska Institutet (KI) in the early hours of Saturday, February 13. In a press release we received at 12:16 a.m. local time in Stockholm, Hamsten issued the following statement: Following the criticism on the so called Macchiarini affair at KI I conclude it will be hard … Continue reading Karolinska vice-chancellor resigns following criticism of Macchiarini investigation

Karolinska orders new investigation of trachea surgeon Macchiarini

The Karolinska Institutet University Board announced today it was issuing a new external investigation of trachea surgeon Paolo Macchiarini, looking into questions about his recruitment and the handling of previous allegations of misconduct. According to a press release: The University Board deems such an inquiry to be an important part of restoring the confidence of the … Continue reading Karolinska orders new investigation of trachea surgeon Macchiarini

Karolinska won’t extend star surgeon Macchiarini’s contract

Karolinska Institutet announced today it would not extend the contract of star surgeon Paolo Macchiarini. He has been instructed to “phase out” his research from now until November 30. According to a press release issued today:

Sharing data is a good thing. But we need to consider the costs.

Last week, the International Committee of Medical Journal Editors proposed requiring authors to share deidentified patient data underlying the published results of clinical trials within six months of publication. The proposal has earned much support but also some concerns – for example that other scientists might poach the findings, acting as the New England Journal of … Continue reading Sharing data is a good thing. But we need to consider the costs.

Investigation of undisclosed conflicts in catheter paper uncovers flawed data, too

An investigation into a paper that compared infection rates from different types of central lines started with an allegation about a failure to disclose a conflict of interest, and ended up concluding that the science in the paper was flawed. The 2013 paper — now retracted by the American Journal of Infection Control — suggested … Continue reading Investigation of undisclosed conflicts in catheter paper uncovers flawed data, too

So, pot may not be as harmless as a recent study suggested

Researchers are correcting a widely covered study that suggested chronic use of pot might not put users at risk of problems later in life. It turns out that initial, unexpected finding — covered by Newsweek, The Washington Post, Quartz, and (of course) The Stoner’s Cookbook (now known as HERB) — wasn’t quite right, and a reanalysis found users had a small uptick … Continue reading So, pot may not be as harmless as a recent study suggested

Former UCSD prof’s company admits to grant fraud

A company headed by a former astrophysicist at the University of California, San Diego, has agreed to forfeit $180,000 after admitting to defrauding the government. If SciberQuest, Inc. is unable to pay back the money — the result of fraudulently obtaining government grants and contracts — then its CEO Homayoun Karimabadi will be personally liable, the lawyer for … Continue reading Former UCSD prof’s company admits to grant fraud

Weekend reads: A celebrity surgeon’s double life; misconduct in sports medicine; researcher loses honor

This week at Retraction Watch featured a literally bullshit excuse for fake data, a new record for time from publication to retraction, and news of an upcoming retraction from Science. Here’s what was happening elsewhere:

Authors retract abstract following misconduct by diabetes biotech

Earlier this year, authors retracted a meeting abstract about a diabetes drug, following the revelation that the biotech that funded the trial committed misconduct. The retraction was initiated by corresponding author Itamar Raz, at Hadassah Medical Center in Israel. The journal didn’t receive a response from any co-authors who were affiliated with the biotech company, Andromeda, so … Continue reading Authors retract abstract following misconduct by diabetes biotech

Cancer researcher contributed “false data” to 11 studies

A former cancer researcher has falsified data in 11 studies, according to the results of a investigation scheduled to be published in the Federal Register tomorrow. The Office of Research Integrity’s findings are based on an inquiry at Virginia Commonwealth University, where Girija Dasmahapatra worked until July of this year, investigating possible therapies for cancer. The … Continue reading Cancer researcher contributed “false data” to 11 studies